KSP Co., Ltd. (KOSDAQ:073010)
4,250.00
+310.00 (7.87%)
At close: Feb 20, 2026
KSP Co., Ltd. Revenue
KSP Co., Ltd. had revenue of 24.22B KRW in the quarter ending September 30, 2025, with 17.79% growth. This brings the company's revenue in the last twelve months to 39.05B, down -31.60% year-over-year. In the year 2012, KSP Co., Ltd. had annual revenue of 50.06B, down -16.71%.
Revenue (ttm)
39.05B
Revenue Growth
-31.60%
P/S Ratio
4.36
Revenue / Employee
309.91M
Employees
126
Market Cap
170.29B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2012 | 50.06B | -10.04B | -16.71% |
| Dec 31, 2011 | 60.10B | 24.05B | 66.70% |
| Dec 31, 2010 | 36.05B | -14.12B | -28.14% |
| Dec 31, 2009 | 50.17B | -16.90B | -25.19% |
| Dec 31, 2008 | 67.07B | 20.90B | 45.28% |
| Dec 31, 2007 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2006 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2005 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2004 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Kukbo Design | 444.12B |
| Amotech | 257.24B |
| Seronics | 182.89B |
| Keeps Biopharma | 157.75B |
| GREEN CROSS WellBeing | 151.06B |
| Purit | 138.95B |
| Dongbang Medical | 111.86B |
| High Tech Pharm | 75.60B |